Evogene Market Cap

Evogene has a market cap or net worth of $7.27 million as of March 6, 2026. Its market cap has decreased by -25.46% in one year.

Market Cap

7.27M

Enterprise Value

8.58M

1-Year Change

-25.46%

Ranking

#5246

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from $19.41M to $7.27M, a decrease of -62.52%. That is a compound annual growth rate of -5.19%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	7.27M	-11.51%
Dec 31, 2025	8.22M	-36.78%
Dec 31, 2024	13.00M	-69.10%
Dec 31, 2023	42.08M	60.85%
Dec 29, 2022	26.16M	-63.27%
Dec 30, 2021	71.23M	-58.31%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Pulmatrix	7.93M
KALA BIO	7.77M
Alaunos Therapeutics	7.59M
GridAI Technologies	7.46M
Alzamend Neuro	7.46M
Kiora Pharmaceuticals	7.45M
PharmaCyte Biotech	6.99M
Mustang Bio	6.93M

Market Cap Rankings